Literature DB >> 8137275

Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene.

G D Kruh1, A Chan, K Myers, K Gaughan, T Miki, S A Aaronson.   

Abstract

The emergence of drug-resistant cancer cells is a major obstacle to cancer treatment. Resistant cells often display a multidrug-resistant phenotype that reduces the promise of combination chemotherapy, the classic approach to the prevention of drug resistance. mdr1, a member of the ABC cassette superfamily of transporters which encodes an energy-dependent drug efflux pump, is the only gene known to confer the multidrug-resistant phenotype. Other multidrug resistance mechanisms must exist, since cell lines which have this phenotype in the absence of mdr1 overexpression have been described. We report here the application of a novel approach involving expression complementary DNA library transfer to the identification of drug-resistant genes. Using this approach we establish that mrp, a member of the ABC cassette superfamily of transporters, is capable of conferring a multidrug-resistant phenotype. This approach should be useful in the identification of other novel resistance genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137275

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.

Authors:  S Paul; L M Breuninger; K D Tew; H Shen; G D Kruh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  MRP subfamily transporters and resistance to anticancer agents.

Authors:  G D Kruh; H Zeng; P A Rea; G Liu; Z S Chen; K Lee; M G Belinsky
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

3.  2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance.

Authors:  Aleem Gangjee; Ojas A Namjoshi; Staci N Keller; Charles D Smith
Journal:  Bioorg Med Chem       Date:  2011-05-23       Impact factor: 3.641

4.  Expression of multidrug resistance-associated protein (MRP) in human gliomas.

Authors:  M Mohri; H Nitta; J Yamashita
Journal:  J Neurooncol       Date:  2000-09       Impact factor: 4.130

5.  Establishment and characterization of a multidrug-resistant human bladder carcinoma cell line RT112/D21.

Authors:  O Seemann; M Muscheck; M Siegsmund; H Pilch; C T Nebe; J Rassweiler; P Alken
Journal:  Urol Res       Date:  1995

6.  Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.

Authors:  G J Zaman; J Lankelma; O van Tellingen; J Beijnen; H Dekker; C Paulusma; R P Oude Elferink; F Baas; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.

Authors:  V D Makhey; A Guo; D A Norris; P Hu; J Yan; P J Sinko
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

8.  Molecular cloning and expression of a cyclic AMP-activated chloride conductance regulator: a novel ATP-binding cassette transporter.

Authors:  M A van Kuijck; R A van Aubel; A E Busch; F Lang; F G Russel; R J Bindels; C H van Os; P M Deen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia.

Authors:  Hee Jin Huh; Chan Jeoung Park; Seongsoo Jang; Eul Ju Seo; Hyun Sook Chi; Je Hwan Lee; Kyoo Hyung Lee; Jong Jin Seo; Hyung Nam Moon; Thad Ghim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

10.  Discovery of novel antitumor antimitotic agents that also reverse tumor resistance.

Authors:  Aleem Gangjee; Jianming Yu; Jean E Copper; Charles D Smith
Journal:  J Med Chem       Date:  2007-06-14       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.